Cargando…

Cerebrospinal Fluid Profile of Lipid Mediators in Alzheimer’s Disease

Alzheimer’s disease (AD) develops into dementia over a period of several years, during which subjective cognitive impairment (SCI) and mild cognitive impairment (MCI) can be used as intermediary diagnoses of increasing severity. Chronic neuroinflammation resulting from insufficient resolution is inv...

Descripción completa

Detalles Bibliográficos
Autores principales:	Do, Khanh V., Hjorth, Erik, Wang, Ying, Jun, Bokkyoo, Kautzmann, Marie-Audrey I., Ohshima, Makiko, Eriksdotter, Maria, Schultzberg, Marianne, Bazan, Nicolas G.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer US 2022
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9957874/ https://www.ncbi.nlm.nih.gov/pubmed/35362880 http://dx.doi.org/10.1007/s10571-022-01216-5

Ejemplares similares

Age-related changes in brain phospholipids and bioactive lipids in the APP knock-in mouse model of Alzheimer’s disease
por: Emre, Ceren, et al.
Publicado: (2021)

Intranasal delivery of pro-resolving lipid mediators rescues memory and gamma oscillation impairment in App(NL-G-F/NL-G-F) mice
por: Emre, Ceren, et al.
Publicado: (2022)

Membrane‐type frizzled‐related protein regulates lipidome and transcription for photoreceptor function
por: Kautzmann, Marie‐Audrey I., et al.
Publicado: (2019)

Elovanoids counteract oligomeric β-amyloid-induced gene expression and protect photoreceptors
por: Do, Khanh V., et al.
Publicado: (2019)

Can inflammation be resolved in Alzheimer’s disease?
por: Zhu, Mingqin, et al.
Publicado: (2018)

Elovanoids are novel cell-specific lipid mediators necessary for neuroprotective signaling for photoreceptor cell integrity
por: Jun, Bokkyoo, et al.
Publicado: (2017)

Cerebrospinal Fluid Alzheimer Markers in Depressed Elderly Subjects with and without Alzheimer's Disease
por: Kramberger, Milica Gregoric, et al.
Publicado: (2012)

Receptors for pro‐resolving mediators are increased in Alzheimer's disease brain
por: Emre, Ceren, et al.
Publicado: (2020)

Elovanoids are a novel class of homeostatic lipid mediators that protect neural cell integrity upon injury
por: Bhattacharjee, Surjyadipta, et al.
Publicado: (2017)

Elovanoids downregulate SARS-CoV-2 cell-entry, canonical mediators and enhance protective signaling in human alveolar cells
por: Calandria, Jorgelina M., et al.
Publicado: (2021)

Metabolite Profiling of Alzheimer's Disease Cerebrospinal Fluid
por: Czech, Christian, et al.
Publicado: (2012)

New Retinal Pigment Epithelial Cell Model to Unravel Neuroprotection Sensors of Neurodegeneration in Retinal Disease
por: Asatryan, Aram, et al.
Publicado: (2022)

Effects of Immunomodulatory Substances on Phagocytosis of Aβ (1–42) by Human Microglia
por: Hjorth, Erik, et al.
Publicado: (2010)

Profiling of Cerebrospinal Fluid Lipids and Their Relationship with Plasma Lipids in Healthy Humans
por: Saito, Kosuke, et al.
Publicado: (2021)

Retinal Pigment Epithelium and Photoreceptor Preconditioning Protection Requires Docosanoid Signaling
por: Knott, Eric J., et al.
Publicado: (2017)

CSF and Plasma Cholinergic Markers in Patients With Cognitive Impairment
por: Karami, Azadeh, et al.
Publicado: (2021)

Tau oligomers in cerebrospinal fluid in Alzheimer's disease
por: Sengupta, Urmi, et al.
Publicado: (2017)

A diagnostic scale for Alzheimer’s disease based on cerebrospinal fluid biomarker profiles
por: Lehmann, Sylvain, et al.
Publicado: (2014)

Insufficient Resolution Response in the Hippocampus of a Senescence-Accelerated Mouse Model — SAMP8
por: Wang, Xiuzhe, et al.
Publicado: (2014)

The cerebrospinal fluid biomarker profile in an HIV-infected subject with Alzheimer’s disease
por: Mäkitalo, Signar, et al.
Publicado: (2015)

Proteome profiling in cerebrospinal fluid reveals novel biomarkers of Alzheimer's disease
por: Bader, Jakob M, et al.
Publicado: (2020)

Distinct Cerebrospinal Fluid Lipid Signature in Patients with Subarachnoid Hemorrhage-Induced Hydrocephalus
por: Toft-Bertelsen, Trine L., et al.
Publicado: (2023)

Cerebrospinal fluid tau, neurogranin, and neurofilament light in Alzheimer's disease
por: Mattsson, Niklas, et al.
Publicado: (2016)

Cerebrospinal Fluid Protein Profiles in Alzheimer’s Dementia Patients: A Bioinformatic Approach
por: Misra, Anamika, et al.
Publicado: (2023)

Immunomodulatory lipid mediator profiling of cerebrospinal fluid following surgery in older adults
por: Terrando, Niccolò, et al.
Publicado: (2021)

Analysis of the Cerebrospinal Fluid Proteome in Alzheimer's Disease
por: Khoonsari, Payam Emami, et al.
Publicado: (2016)

Alzheimer disease pathology and the cerebrospinal fluid proteome
por: Dayon, Loïc, et al.
Publicado: (2018)

Cerebrospinal fluid in Alzheimer's: A precious tool
por: Parnetti, Lucilla, et al.
Publicado: (2016)

Cerebrospinal fluid biomarker panel for synaptic dysfunction in Alzheimer's disease
por: Nilsson, Johanna, et al.
Publicado: (2021)

Predictive Modeling of Alzheimer’s and Parkinson’s Disease Using Metabolomic and Lipidomic Profiles from Cerebrospinal Fluid
por: Hwangbo, Nathan, et al.
Publicado: (2022)

Altered microRNA profiles in cerebrospinal fluid exosome in Parkinson disease and Alzheimer disease
por: Gui, YaXing, et al.
Publicado: (2015)

Differential proteomic profile of lumbar and ventricular cerebrospinal fluid
por: Rostgaard, Nina, et al.
Publicado: (2023)

Lipid profile of cerebrospinal fluid in multiple sclerosis patients: a potential tool for diagnosis
por: Nogueras, L., et al.
Publicado: (2019)

Phosphotyrosine profiling of human cerebrospinal fluid
por: Sathe, Gajanan, et al.
Publicado: (2018)

Elevated cerebrospinal fluid pressure in patients with Alzheimer's disease
por: Silverberg, Gerald, et al.
Publicado: (2006)

Alzheimer’s Disease: Biomarkers in the Genome, Blood, and Cerebrospinal Fluid
por: Huynh, Rose Ann, et al.
Publicado: (2017)

Cerebrospinal fluid biomarkers for Alzheimer's disease in Down syndrome
por: Dekker, Alain D., et al.
Publicado: (2017)

A cerebrospinal fluid biosignature for the diagnosis of Alzheimer’s disease
por: Barichello, Tatiana, et al.
Publicado: (2019)

Putative autoantibodies in the cerebrospinal fluid of Alzheimer’s disease patients
por: Lim, Bryant, et al.
Publicado: (2019)

Interplay between human microglia and neural stem/progenitor cells in an allogeneic co-culture model
por: Liu, Jia, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_sdcena7s9gr78246bfmdk7fcm7